Tag: biosimilar insulin glargine
Lannett gets FDA nod for clinical trial of biosimilar insulin glargine
Lannett Company has been given clearance from the US Food and Drug Administration (FDA) to proceed with a clinical trial of biosimilar insulin glargine. The ... Read More